Items where Author is "Hoelscher, M."

2022

Mekota, AM. and Gillespie, SH. and Hoelscher, M. and Diacon, AH. and Dawson, R. and Churchyard, G. and Sanne, I. and Minja, L. and Kibiki, G. and Maboko, L. and Lakhi, S. and Joloba, M. and Alabi, A. and Kirenga, B. and McHugh, TD. and Grobusch, MP. and Boeree, MJ. and PanAcea consortium, . (2022) Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: the PanACEA approach. Acta Trop, 238. p. 106776.

Ntinginya, N. E. and Bakuli, A. and Mapamba, D. and Sabiiti, W. and Kibiki, G. and Minja, L. T. and Kuchaka, D. and Reither, K. and Phillips, P. P. J. and Boeree, M. J. and Gillespie, S. H. and Hoelscher, M. and Heinrich, N.. (2022) TB-molecular bacterial load assay reveals early delayed bacterial killing in relapse patients. Clinical infectious diseases. in press.

2017

Boeree, M. J. and Heinrich, N. and Aarnoutse, R. and Diacon, A. H. and Dawson, R. and Rehal, S. and Kibiki, G. S. and Churchyard, G. and Sanne, I. and Ntinginya, N. E. and Minja, L. T. and Hunt, R. D. and Charalambous, S. and Hanekom, M. and Semvua, H. and Mpagama, S. G. and Manyama, C. and Mtafya, B. and Reither, K. and Wallis, R. S. and Venter, A. and Narunsky, K. and Mekota, A. and Henne, S. and Colbers, A. and van Balen, G. P. and Gillespie, S. H. and Phillips, P. P. J. and Hoelscher, M.. (2017) High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial. The Lancet infectious diseases, 17 (1). pp. 39-49.

Aarnoutse, R. E. and Kibiki, G. S. and Reither, K. and Semvua, H. H. and Haraka, F. and Mtabho, C. M. and Mpagama, S. G. and van den Boogaard, J. and Sumari-de Boer, I. M. and Magis-Escurra, C. and Wattenberg, M. and Logger, J. G. M. and Te Brake, L. H. M. and Hoelscher, M. and Gillespie, S. H. and Colbers, A. and Phillips, P. P. J. and Plemper van Balen, G. and Boeree, M. J.. (2017) Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB. Antimicrobial agents and chemotherapy, 61 (11). e01054-17.

2015

Olaru, I. D. and Rachow, A. and Lange, C. and Ntinginya, N. E. and Reither, K. and Hoelscher, M. and Vollrath, O. and Niemann, S.. (2015) Ascertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania. The international journal of tuberculosis and lung disease, Vol. 19, H. 1. pp. 70-73.

Steiner, A. and Mangu, C. and van den Hombergh, J. and van Deutekom, H. and van Ginneken, B. and Clowes, P. and Mhimbira, F. and Mfinanga, S. and Rachow, A. and Reither, K. and Hoelscher, M.. (2015) Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays. Public health action, 5 (4). pp. 249-254.

Zumla, A. and Chakaya, J. and Hoelscher, M. and Ntoumi, F. and Rustomjee, R. and Vilaplana, C. and Yeboah-Manu, D. and Rasolof, V. and Munderi, P. and Singh, N. and Aklillu, E. and Padayatchi, N. and Macete, E. and Kapata, N. and Mulenga, M. and Kibiki, G. and Mfinanga, S. and Nyirenda, T. and Maboko, L. and Garcia-Basteiro, A. and Rakotosamimanana, N. and Bates, M. and Mwaba, P. and Reither, K. and Gagneux, S. and Edwards, S. and Mfinanga, E. and Abdulla, S. and Cardona, P. J. and Russell, J. B. and Gant, V. and Noursadeghi, M. and Elkington, P. and Bonnet, M. and Menendez, C. and Dieye, T. N. and Diarra, B. and Maiga, A. and Aseffa, A. and Parida, S. and Wejse, C. and Petersen, E. and Kaleebu, P. and Oliver, M. and Craig, G. and Corrah, T. and Tientcheu, L. and Antonio, M. and Rao, M. and McHugh, T. D. and Sheikh, A. and Ippolito, G. and Ramjee, G. and Kaufmann, S. H. and Churchyard, G. and Steyn, A. and Grobusch, M. and Sanne, I. and Martinson, N. and Madansein, R. and Wilkinson, R. J. and Mayosi, B. and Schito, M. and Wallis, R. S. and Maeurer, M.. (2015) Towards host-directed therapies for tuberculosis. Nature reviews. Drug discovery, 14 (8). pp. 511-512.

2012

Rachow, A. and Clowes, P. and Saathoff, E. and Mtafya, B. and Michael, E. and Ntinginya, E. N. and Kowour, D. and Rojas-Ponce, G. and Kroidl, A. and Maboko, L. and Heinrich, N. and Reither, K. and Hoelscher, M.. (2012) Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis : a prospective cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 54, H. 10. pp. 1388-1396.

Ntinginya, E. N. and Squire, S. B. and Millington, K. A. and Mtafya, B. and Saathoff, E. and Heinrich, N. and Rojas-Ponce, G. and Kowuor, D. and Maboko, L. and Reither, K. and Clowes, P. and Hoelscher, M. and Rachow, A.. (2012) Performance of the Xpert® MTB/RIF assay in an active case-finding strategy : a pilot study from Tanzania. The international journal of tuberculosis and lung disease : the official journal of the International Union Against Tuberculosis and Lung Disease, Vol. 16, H. 11. pp. 1468-1470.

2011

Rachow, A. and Zumla, A. and Heinrich, N. and Rojas-Ponce G., and Mtafya, B. and Reither, K. and Ntinginya, E. N. and O'Grady J., and Huggett, J. and Dheda, K. and Boehme, C. and Perkins, M. and Saathoff, E. and Hoelscher, M.. (2011) Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay : a clinical validation study. PLoS ONE, Vol. 6, H. 6 , e20458.